Understanding the Legal Risks of BPC-157 and Other Unapproved Peptides The Peptide Compliance Crisis: Regulatory Enforcement and Liability Risks of BPC-157 The massive commercial rise of regenerative medicine and anti-aging therapies has placed synthetic peptides like BPC-157 (Body Protection Compound-157) at the center of clinical wellness models
Statement of Disclosure In accordance with the Accreditation Council for Pharmacy Education (ACPE) Standards for Continuing Pharmacy Education, The University of Rhode Island College of Pharmacy requires that program faculty disclose any relationship (e.g., shareholder, recipient of research grant, consultant or member of an advisory committee) that the faculty may have with commercial companies whose products or services may be mentioned in their presentations
They then evaluated the repeatability of the study findings among type 2 diabetes patients from different periods
PLoS ONE 10:e0131177 Behrens CR, Ha EH, Chinn LL, Bowers S, Probst G, Fitch-Bruhns M, Monteon J, Valdiosera A, Bermudez A, Liao-Chan S et al (2015) Antibody-drug conjugates (ADCs) derived from interchain cysteine cross-linking demonstrate improved homogeneity and other pharmacological properties over conventional heterogeneous ADCs
Terpenoids as potential geroprotectors
2008 Mar 13;51(5):1189-202
